- Home
- Publications
- Publication Search
- Publication Details
Title
Urinary CE-MS peptide marker pattern for detection of solid tumors
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-29
DOI
10.1038/s41598-018-23585-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
- (2016) Maria Frantzi et al. CLINICAL CANCER RESEARCH
- Urinary Peptide Analysis Differentiates Pancreatic Cancer From Chronic Pancreatitis
- (2016) Bastian Schönemeier et al. PANCREAS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
- (2014) Mildred Felder et al. Molecular Cancer
- Remodelling the extracellular matrix in development and disease
- (2014) Caroline Bonnans et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions
- (2014) Ali Tuzun Ince et al. Turkish Journal of Gastroenterology
- Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine
- (2013) Julie Klein et al. ELECTROPHORESIS
- Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer
- (2013) Björg Kristjansdottir et al. GYNECOLOGIC ONCOLOGY
- Discovery and validation of urinary biomarkers for detection of renal cell carcinoma
- (2013) Maria Frantzi et al. Journal of Proteomics
- Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation
- (2013) E M Weissinger et al. LEUKEMIA
- Active surveillance for prostate cancer
- (2012) Eric A. Singer et al. CURRENT OPINION IN ONCOLOGY
- Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders
- (2012) Jochen Metzger et al. GUT
- Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers
- (2011) Mohammed Dakna et al. BMC BIOINFORMATICS
- Human urinary peptide database for multiple disease biomarker discovery
- (2011) Justyna Siwy et al. Proteomics Clinical Applications
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
- (2010) David M. Good et al. MOLECULAR & CELLULAR PROTEOMICS
- Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
- (2010) H. Mischak et al. Science Translational Medicine
- The global burden of cancer: priorities for prevention
- (2009) M. J. Thun et al. CARCINOGENESIS
- Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma
- (2008) Paul Wheatley-Price et al. CANCER
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Discovery and validation of urinary biomarkers for prostate cancer
- (2008) Dan Theodorescu et al. Proteomics Clinical Applications
- Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
- (2008) Vathany Kulasingam et al. Nature clinical practice. Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now